Larvol Delta - Clinical-Outcomes-at-Week-52-in-Male-and-Female-Patients-With-PsA-Treated-With-Deucravacitinib-A-Pooled-Analysis-of-Pivotal-Phase-3-Studies

Sotyktu (deucravacitinib) - BMS

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1898156&mode=presInfo

Brittany Weber, MD, PhD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next